Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemiaD Maraninchi, N Vey, P Viens, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Blood|June 8, 2001
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remissionD Blaise, D Maraninchi, M Michallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Pathologie-Biologie|June 30, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]D Blaise, S Nguyen, J-O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.
Bone Marrow Transplantation|October 27, 2015
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working PartiesO Penack, G Tridello, J Hoek, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemiaD Maraninchi, N Vey, P Viens, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Blood|June 8, 2001
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remissionD Blaise, D Maraninchi, M Michallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Pathologie-Biologie|June 30, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]D Blaise, S Nguyen, J-O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.
Bone Marrow Transplantation|October 27, 2015
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working PartiesO Penack, G Tridello, J Hoek, et al.
Pageof 29